Targeting macrophage subtypes as a strategy for chronic inflammatory lung disease therapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1080274

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Researchers in Melbourne have discovered a possible cause of severe emphysema. Using disease models, patients’ samples and advanced genetic techniques they are now searching for ways to turn this discovery into effective treatments for this disease which is currently fatal and incurable.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $660,471.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

alveolar macrophages | chronic obstructive pulmonary disease (COPD) | lung function | lung inflammation | macrophage biology

Related Links